Edition:
United States

Grifols SA (GRFS.OQ)

GRFS.OQ on NASDAQ Stock Exchange Global Select Market

21.13USD
21 Sep 2018
Change (% chg)

$-0.26 (-1.22%)
Prev Close
$21.39
Open
$21.13
Day's High
$21.34
Day's Low
$21.08
Volume
228,017
Avg. Vol
182,682
52-wk High
$25.17
52-wk Low
$19.85

Chart for

About

No overview information found for .

Overall

No Ratios Available.

Financials

  GRFS.OQ Industry Sector
P/E (TTM): -- 30.49 32.71
EPS (TTM): -- -- --
ROI: -- 13.04 12.72
ROE: -- 14.98 14.84

Healthcare firm Grifols S.A. wins U.S. antitrust nod to buy Biotest US Corp

WASHINGTON Global healthcare company, Grifols S.A. , which is based in Spain, has won U.S. antitrust approval to buy Biotest US Corp on condition that it sells certain assets, the Federal Trade Commission said on Wednesday.

Aug 01 2018

Healthcare firm Grifols S.A. wins US antitrust nod to buy Biotest US Corp

WASHINGTON, Aug 1 Global healthcare company, Grifols S.A., which is based in Spain, has won U.S. antitrust approval to buy Biotest US Corp on condition that it sells certain assets, the Federal Trade Commission said on Wednesday.

Aug 01 2018

Spanish stocks - Factors to watch on Friday

The following Spanish stocks may be affected by newspaper reports and other factors on Firday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy:

May 25 2018

BRIEF-Grifols Expands Its Blood Typing Solutions Portfolio In US With Antisera Reagents

* GRIFOLS EXPANDS ITS BLOOD TYPING SOLUTIONS PORTFOLIO IN THE UNITED STATES WITH ANTISERA REAGENTS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

May 14 2018

BRIEF-Grifols Q1 EBITDA Down 2.8 Pct At 297 Mln Euros YoY

* Q1 EBITDA 297.4 MILLION EUROS VERSUS 306.0 MILLION EUROS YEAR AGO

May 03 2018

Earnings vs. Estimates